TY  - JOUR
AU  - Moen, Christian A
AU  - Falkenthal, Thea E
AU  - Thorkelsen, Tor K
AU  - Hopland, Andreas
AU  - Rio, Oline E
AU  - Honoré, Alfred
AU  - Juliebø-Jones, Patrick
AU  - Dongre, Harsh N
AU  - Costea, Daniela E
AU  - Bostad, Leif
AU  - Brennan, Paul
AU  - Johansson, Mattias
AU  - Ferreiro-Iglesias, Aida
AU  - Brenner, Nicole
AU  - Waterboer, Tim
AU  - Nygård, Mari
AU  - Beisland, Christian
TI  - Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years.
JO  - European urology oncology
VL  - 7
IS  - 4
SN  - 2588-9311
CY  - Amsterdam
PB  - Elsevier
M1  - DKFZ-2023-02340
SP  - 778-785
PY  - 2024
N1  - 2024 Aug;7(4):778-785
AB  - Human papillomavirus (HPV) infection is a risk factor for the development of penile squamous cell carcinoma (PSCC). It remains inconclusive whether HPV-related PSCC has a different prognosis from non-HPV-related PSCC.To investigate the relationship between HPV status and survival as well as temporal changes in the proportion of HPV-related PSCC.A retrospective cohort of 277 patients treated in Norway between 1973 and 2022 was investigated for HPV DNA in tumor tissue. Clinicopathological variables and disease course were registered.Kaplan-Meier curves and Cox regression were used to investigate the determinants of cancer-specific survival (CSS). The chi-square test for trend in proportions enabled investigation of temporal changes in the HPV-related proportion of PSCC patients treated in Western Norway (n = 211).HPV DNA was detected in tumor tissue from 131 (47
KW  - Cancer-specific survival (Other)
KW  - Human papillomavirus (Other)
KW  - Net survival (Other)
KW  - Penile cancer (Other)
KW  - Penile squamous cell carcinoma (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:37949729
DO  - DOI:10.1016/j.euo.2023.10.013
UR  - https://inrepo02.dkfz.de/record/285371
ER  -